Mersana Therapeutics buy Wedbush
Start price
03.03.25
/
50%
€0.47
Target price
03.03.26
€3.81
Performance (%)
-44.40%
Price
25.07.25
€0.26
Summary
This prediction is currently active. The BUY prediction by Wedbush for Mersana Therapeutics is performing very badly with a performance of -44.40%. This prediction currently runs until 03.03.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | - | - |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Wedbush for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
Stopped prediction by Wedbush for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.28
15.05.25
15.05.25
€2.68
15.05.26
15.05.26
-7.18%
25.07.25
25.07.25
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.28
06.05.25
06.05.25
€2.66
06.05.26
06.05.26
-5.30%
25.07.25
25.07.25